PROCEPT Biorobotics Corp. 8-K Summary
Business Context and Reporting Period
PROCEPT Biorobotics Corporation (PRCT), an emerging growth company incorporated in Delaware, filed this Form 8-K on January 11, 2022. The filing announces preliminary revenue results for the quarter and fiscal year ended December 31, 2021.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It serves as a notification that these preliminary results were issued in a press release (Exhibit 99.1) rather than containing the data directly within the 8-K body.
Material Changes
No material changes or comparative financial data versus prior periods are detailed in the text of this filing. The document references the press release for the actual results.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information in this report and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section. No specific guidance, management commentary, or risk factors are outlined in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated January 11, 2022) for the actual preliminary revenue figures for Q4 and FY 2021.
- Verify the company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.
- Confirm the trading symbol (PRCT) and exchange (Nasdaq) for the common stock.